debrisoquin has been researched along with Adenocarcinoma in 3 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sugimura, H | 1 |
Caporaso, NE | 2 |
Shaw, GL | 1 |
Modali, RV | 1 |
Gonzalez, FJ | 1 |
Hoover, RN | 2 |
Resau, JH | 1 |
Trump, BF | 1 |
Weston, A | 1 |
Harris, CC | 1 |
Speirs, CJ | 1 |
Murray, S | 1 |
Davies, DS | 1 |
Biola Mabadeje, AF | 1 |
Boobis, AR | 1 |
Tucker, MA | 1 |
Hayes, RB | 1 |
Pickle, LW | 1 |
Issaq, HJ | 1 |
Muschik, GM | 1 |
Green-Gallo, L | 1 |
Buivys, D | 1 |
Aisner, S | 1 |
3 other studies available for debrisoquin and Adenocarcinoma
Article | Year |
---|---|
Human debrisoquine hydroxylase gene polymorphisms in cancer patients and controls.
Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cytochrome P-450 CYP2D6; Cytochrome | 1990 |
Debrisoquine oxidation phenotype and susceptibility to lung cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Debrisoqui | 1990 |
Lung cancer and the debrisoquine metabolic phenotype.
Topics: Adenocarcinoma; Case-Control Studies; Debrisoquin; Female; Humans; Isoquinolines; Lung Diseases, Obs | 1990 |